AAAAAA
Results:
1-15
|
Results: 15
Authors:
Petzinger, GM
Quik, M
Ivashina, E
Jakowec, MW
Jakubiak, M
Di Monte, D
Langston, JW
Citation: Gm. Petzinger et al., Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate, MOVEMENT D, 16(2), 2001, pp. 202-207
Authors:
Togasaki, DM
Tan, L
Protell, P
Di Monte, DA
Quik, M
Langston, JW
Citation: Dm. Togasaki et al., Levodopa induces dyskinesias in normal squirrel monkeys, ANN NEUROL, 50(2), 2001, pp. 254-257
Authors:
Quik, M
Polonskaya, Y
Kulak, JM
McIntosh, JM
Citation: M. Quik et al., Vulnerability of I-125-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey, J NEUROSC, 21(15), 2001, pp. 5494-5500
Authors:
Quik, M
Di Monte, DA
Citation: M. Quik et Da. Di Monte, Nicotine administration reduces striatal MPP plus levels in mice, BRAIN RES, 917(2), 2001, pp. 219-224
Authors:
Jeyarasasingam, G
Yeluashvili, M
Quik, M
Citation: G. Jeyarasasingam et al., Tacrine, a reversible acetylcholinesterase inhibitor, induces myopathy, NEUROREPORT, 11(6), 2000, pp. 1173-1176
Authors:
Di Monte, DA
McCormack, A
Petzinger, G
Janson, AM
Quik, M
Langston, WJ
Citation: Da. Di Monte et al., Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model, MOVEMENT D, 15(3), 2000, pp. 459-466
Authors:
Langston, JW
Quik, M
Petzinger, G
Jakowec, M
Di Monte, DA
Citation: Jw. Langston et al., Investigating levodopa-induced dyskinesias in the Parkinsonian primate, ANN NEUROL, 47(4), 2000, pp. S79-S89
Authors:
He, L
Di Monte, DA
Langston, JW
Quik, M
Citation: L. He et al., Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and levodopa treatment, NEUROSCIENC, 99(4), 2000, pp. 697-704
Authors:
Quik, M
Police, S
He, L
Di Monte, DA
Langston, JW
Citation: M. Quik et al., Expression of D-3 receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: Effect of levodopa treatment, NEUROSCIENC, 98(2), 2000, pp. 263-273
Authors:
Quik, M
Polonskaya, Y
Gillespie, A
Lloyd, GK
Langston, JW
Citation: M. Quik et al., Differential alterations in nicotinic receptor alpha 6 and beta 3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration, NEUROSCIENC, 100(1), 2000, pp. 63-72
Authors:
Jeyarasasingam, G
Yeluashvili, M
Quik, M
Citation: G. Jeyarasasingam et al., Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats, J PHARM EXP, 295(1), 2000, pp. 314-320
Authors:
Quik, M
Polonskaya, Y
Gillespie, A
Jakowec, M
Lloyd, GK
Langston, JM
Citation: M. Quik et al., Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization, J COMP NEUR, 425(1), 2000, pp. 58-69
Authors:
Quik, M
Jeyarasasingam, G
Citation: M. Quik et G. Jeyarasasingam, Nicotinic receptors and Parkinson's disease, EUR J PHARM, 393(1-3), 2000, pp. 223-230
Authors:
He, L
Di Monte, DA
Langston, JW
Quik, M
Citation: L. He et al., Autoradiographic analysis of dopamine receptor-stimulated [S-35]GTP gamma S binding in rat striatum, BRAIN RES, 885(1), 2000, pp. 133-136
Authors:
Lukas, RJ
Changeux, JP
Le Novere, N
Albuquerque, EX
Balfour, DJK
Berg, DK
Bertrand, D
Chiappinelli, VA
Clarke, PBS
Collins, AC
Dani, JA
Grady, SR
Kellar, KJ
Lindstrom, JM
Marks, MJ
Quik, M
Taylor, PW
Wonnacott, S
Citation: Rj. Lukas et al., International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits, PHARM REV, 51(2), 1999, pp. 397-401
Risultati:
1-15
|